UPDATED May 31, 2025
Explore the Australian (ASX) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ZLD | AU$0.51 | 2.0% | 7.4% | AU$6.0m | n/a | PS147x | n/a | n/a | ||
PAB | AU$0.0015 | 0% | -78.6% | AU$3.1m | n/a | PS2.1x | n/a | n/a | ||
WFL | AU$0.003 | 0% | -87.0% | AU$1.5m | n/a | PE-0.2x | n/a | n/a | ||
IDT | AU$0.10 | 0% | 5.0% | AU$45.1m | n/a | PS2.4x | n/a | n/a | ||
TRP | AU$0.18 | 0% | -19.6% | AU$11.2m | n/a | PS4.7x | n/a | n/a | ||
NSB | AU$0.058 | 0% | 18.4% | AU$8.4m | n/a | PE7.1x | n/a | n/a | ||
EPN | AU$0.024 | 0% | 20.0% | AU$7.2m | n/a | PB0.8x | n/a | n/a | ||
ACR | AU$0.023 | 0% | -71.6% | AU$9.4m | n/a | PS11.7x | E106.9% | 0% | ||
CYP | AU$0.18 | 0% | -46.3% | AU$40.7m | n/a | PS23.4x | E84.7% | n/a | ||
MVP | AU$0.65 | 0% | 52.9% | AU$73.2m | AU$2.31 | PS1.9x | E94.6% | 0% | ||
1AI | AU$0.006 | 0% | -45.5% | AU$10.1m | n/a | PS80.9x | n/a | n/a | ||
CAN | AU$0.014 | 0% | n/a | AU$8.7m | n/a | PB1.4x | n/a | n/a | ||
CHM | AU$0.004 | 0% | -77.8% | AU$8.1m | n/a | PS3.9x | n/a | n/a | ||
IMM | AU$0.28 | 0% | -36.7% | AU$416.2m | AU$1.16 | PS85.3x | E42.4% | n/a | ||
VBS | AU$0.06 | 0% | -53.8% | AU$3.2m | n/a | PS3.6x | n/a | n/a | ||
CMB | AU$0.20 | 0% | -66.7% | AU$3.7m | AU$2.57 | n/a | n/a | n/a | ||
MEM | AU$0.005 | 0% | -44.4% | AU$9.9m | n/a | PS9.2x | n/a | n/a | ||
CTE | AU$0.75 | 0% | -29.9% | AU$36.6m | n/a | PE20x | n/a | 2.7% | ||
ATH | AU$0.011 | 0% | 120.0% | AU$100.4m | n/a | PS27x | E-20.1% | n/a | ||
FRE | AU$0.066 | 0% | 10.0% | AU$14.8m | n/a | PS13.1x | n/a | n/a | ||
AVE | AU$0.005 | 0% | 66.7% | AU$15.9m | n/a | PS14x | n/a | n/a | ||
ANR | AU$0.005 | 0% | -89.4% | AU$1.1m | n/a | PS4.3x | n/a | n/a | ||
HXL | AU$0.013 | 0% | -18.8% | AU$2.2m | n/a | PS35.2x | n/a | n/a | ||
ACW | AU$0.021 | 0% | -27.6% | AU$65.8m | n/a | PS7.3x | S38.4% | n/a |